A detailed history of Palisade Capital Management LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Palisade Capital Management LLC holds 453,829 shares of EBS stock, worth $4.17 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
453,829
Previous 461,648 1.69%
Holding current value
$4.17 Million
Previous $1.17 Million 165.21%
% of portfolio
0.1%
Previous 0.04%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$1.86 - $6.98 $14,543 - $54,576
-7,819 Reduced 1.69%
453,829 $3.1 Million
Q1 2024

May 15, 2024

BUY
$1.5 - $3.41 $16,854 - $38,314
11,236 Added 2.49%
461,648 $1.17 Million
Q4 2023

Feb 14, 2024

SELL
$1.82 - $3.16 $107,221 - $186,165
-58,913 Reduced 11.57%
450,412 $1.08 Million
Q3 2023

Nov 14, 2023

SELL
$3.17 - $7.91 $92,224 - $230,125
-29,093 Reduced 5.4%
509,325 $1.73 Million
Q2 2023

Aug 14, 2023

BUY
$7.35 - $13.21 $180,420 - $324,265
24,547 Added 4.78%
538,418 $3.96 Million
Q1 2023

May 08, 2023

BUY
$7.79 - $16.29 $95,030 - $198,721
12,199 Added 2.43%
513,871 $5.32 Million
Q4 2022

Feb 14, 2023

SELL
$11.0 - $21.45 $278,487 - $543,049
-25,317 Reduced 4.8%
501,672 $5.92 Million
Q3 2022

Nov 14, 2022

SELL
$20.09 - $35.8 $785,338 - $1.4 Million
-39,091 Reduced 6.91%
526,989 $11.1 Million
Q2 2022

Aug 10, 2022

BUY
$27.42 - $43.63 $155,498 - $247,425
5,671 Added 1.01%
566,080 $17.6 Million
Q1 2022

May 09, 2022

SELL
$36.48 - $52.22 $895,511 - $1.28 Million
-24,548 Reduced 4.2%
560,409 $23 Million
Q4 2021

Feb 10, 2022

SELL
$33.11 - $55.01 $1.94 Million - $3.22 Million
-58,507 Reduced 9.09%
584,957 $25.4 Million
Q3 2021

Nov 15, 2021

BUY
$50.07 - $66.05 $2.05 Million - $2.71 Million
40,984 Added 6.8%
643,464 $32.2 Million
Q2 2021

Aug 12, 2021

SELL
$56.61 - $80.46 $1.33 Million - $1.89 Million
-23,489 Reduced 3.75%
602,480 $38 Million
Q1 2021

May 12, 2021

BUY
$86.23 - $125.19 $4.05 Million - $5.88 Million
46,960 Added 8.11%
625,969 $58.2 Million
Q4 2020

Feb 11, 2021

BUY
$79.17 - $111.47 $11.9 Million - $16.7 Million
150,134 Added 35.01%
579,009 $51.9 Million
Q3 2020

Nov 12, 2020

BUY
$81.91 - $134.94 $4.82 Million - $7.94 Million
58,825 Added 15.9%
428,875 $44.3 Million
Q2 2020

Aug 06, 2020

BUY
$54.33 - $89.52 $9.21 Million - $15.2 Million
169,448 Added 84.47%
370,050 $29.3 Million
Q1 2020

May 13, 2020

BUY
$49.34 - $68.76 $3.73 Million - $5.2 Million
75,686 Added 60.59%
200,602 $11.6 Million
Q4 2019

Feb 04, 2020

BUY
$51.21 - $59.06 $6.4 Million - $7.38 Million
124,916 New
124,916 $6.74 Million

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $458M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Palisade Capital Management LLC Portfolio

Follow Palisade Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palisade Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palisade Capital Management LLC with notifications on news.